Research.Patient.info
Transthyretin Cardiac Amyloidosis research hub
2 indexed studies · 1 currently recruiting
- recruiting
Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis
This study is testing a new artificial intelligence (AI) tool, called Willem™, to see if it can spot a heart condition called Transthyretin Cardiac Amyloidosis (ATTR-CA) from a standard heart tracing (ECG). Early detection of this condition is important for better treatment.
United States · France · Germany - authorisedTherapeutic use (Phase IV)
HeArt Rate and quality of Life in transthyrEtin cardiac amYloidosis (HARLEY)
This study looks at how heart rate affects people with a heart condition called transthyretin cardiac amyloidosis. It's called HARLEY and wants to see if changes in heart rate influence how well people feel and live their daily lives.
Italy